These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35227424)

  • 21. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Sun LY; Tu JV; Bader Eddeen A; Liu PP
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does treatment improve prognosis of heart failure with preserved ejection fraction?].
    Schläpfer-Pessina A; Carballo S; Perrier A; Garin N
    Rev Med Suisse; 2015 Jan; 11(458):199-205. PubMed ID: 25831613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
    Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
    Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo acute heart failure: Clinical features and one-year mortality in the Spanish nationwide Registry of Acute Heart Failure.
    Franco J; Formiga F; Corbella X; Conde-Martel A; Llácer P; Álvarez Rocha P; Ormaechea Gorricho G; Satué J; Soler Rangel L; Manzano L; Montero-Pérez-Barquero M; ;
    Med Clin (Barc); 2019 Feb; 152(4):127-134. PubMed ID: 30712652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
    Kristensen SL; Køber L; Jhund PS; Solomon SD; Kjekshus J; McKelvie RS; Zile MR; Granger CB; Wikstrand J; Komajda M; Carson PE; Pfeffer MA; Swedberg K; Wedel H; Yusuf S; McMurray JJ
    Circulation; 2015 Jan; 131(1):43-53. PubMed ID: 25406306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival After Coronary Artery Bypass Grafting in Patients With Preoperative Heart Failure and Preserved vs Reduced Ejection Fraction.
    Dalén M; Lund LH; Ivert T; Holzmann MJ; Sartipy U
    JAMA Cardiol; 2016 Aug; 1(5):530-8. PubMed ID: 27434816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
    Hoong CW; Lim CP; Gao F; Chen Q; Kawa LB; Ching CK; Sim DK
    J Cardiovasc Med (Hagerstown); 2015 Sep; 16(9):583-90. PubMed ID: 25022929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and echocardiographic characteristics of patients with preserved versus mid-range ejection fraction.
    Marai I; Andria N; Grosman-Rimon L; Hazanov E; Kinany W; Ghanim D; Amir O; Carasso S
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):503-508. PubMed ID: 32959095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of medication practices in patients with heart failure and preserved versus those with reduced ejection fraction (from the Cardiovascular Research Network [CVRN]).
    Goldberg RJ; Gurwitz JH; Saczynski JS; Hsu G; McManus DD; Magid DJ; Smith DH; Go AS;
    Am J Cardiol; 2013 May; 111(9):1324-9. PubMed ID: 23380451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mid-range Ejection Fraction Does Not Permit Risk Stratification Among Patients Hospitalized for Heart Failure.
    Gómez-Otero I; Ferrero-Gregori A; Varela Román A; Seijas Amigo J; Pascual-Figal DA; Delgado Jiménez J; Álvarez-García J; Fernández-Avilés F; Worner Diz F; Alonso-Pulpón L; Cinca J; Gónzalez-Juanatey JR;
    Rev Esp Cardiol (Engl Ed); 2017 May; 70(5):338-346. PubMed ID: 28011188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction.
    Shitara J; Naito R; Kasai T; Endo H; Wada H; Doi S; Konishi H; Tsuboi S; Ogita M; Dohi T; Okazaki S; Miyauchi K; Daida H
    BMC Cardiovasc Disord; 2021 Jan; 21(1):36. PubMed ID: 33446110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings.
    Agra Bermejo R; Cordero A; García-Acuña JM; Gómez Otero I; Varela Román A; Martínez Á; Álvarez Rodríguez L; Abou-Jokh C; Rodríguez-Mañero M; Cid Álvarez B; López-Palop R; Carrillo P; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):820-828. PubMed ID: 29249471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis.
    Berry C; Poppe KK; Gamble GD; Earle NJ; Ezekowitz JA; Squire IB; McMurray JJV; McAlister FA; Komajda M; Swedberg K; Maggioni AP; Ahmed A; Whalley GA; Doughty RN; Tarantini L;
    QJM; 2016 Jun; 109(6):377-382. PubMed ID: 25979270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart Failure with Recovered Ejection Fraction in a Cohort of Elderly Patients with Chronic Heart Failure.
    Trullàs JC; Manzano L; Formiga F; Aramburu-Bodas O; Quesada-Simón MA; Arias-Jiménez JL; García-Escrivá D; Romero-Requena JM; Jordana-Comajuncosa R; Montero-Pérez-Barquero M;
    Cardiology; 2016; 135(3):196-201. PubMed ID: 27428545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of heart failure symptoms and ejection fraction on short- and long-term outcomes for older patients with non-ST-segment elevation myocardial infarction.
    van Diepen S; Chen AY; Wang TY; Alexander KP; Ezekowitz JA; Peterson ED; Roe MT
    Am Heart J; 2014 Feb; 167(2):267-273.e1. PubMed ID: 24439989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of Death in Patients With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF Trial.
    Desai AS; Vaduganathan M; Cleland JG; Claggett BL; Barkoudah E; Finn P; McCausland FR; Yilmaz MB; Lefkowitz M; Shi V; Pfeffer MA; McMurray JJV; Solomon SD
    Circ Heart Fail; 2021 Dec; 14(12):e008597. PubMed ID: 34807713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with atrial fibrillation and mid-range ejection fraction differ in anticoagulation pattern, thrombotic and mortality risk independently of CHA
    Jurin I; Lucijanic M; Jurin H; Starcevic B; Varvodic J; Catic J; Jurisic A; Vitlov P; Sokol Tomic S; Lucijanic J; Hadzibegovic I
    Heart Vessels; 2020 Sep; 35(9):1243-1249. PubMed ID: 32248252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.